Oxbridge Re Holdings - CW24 | 8-K: FY2025 Q3 Revenue: USD 645 K

Revenue: As of FY2025 Q3, the actual value is USD 645 K.

EPS: As of FY2025 Q3, the actual value is USD -0.02.

EBIT: As of FY2025 Q3, the actual value is USD -170 K.

Net premiums earned for the quarter ended September 30, 2025 decreased to $555,000 from $595,000 for the quarter ended September 30, 2024.
Net premiums earned for the nine-months ended September 30, 2025 increased to $1.73 million from $1.71 million for the nine-month period ended September 30, 2024.

Net loss for the quarter ended September 30, 2025 was $187,000, or - $0.02 basic and diluted loss per share compared to a net loss of $540,000, or - $0.09 basic and diluted loss per share, for the quarter ended September 30, 2024.
Net loss for the nine-months ending September 30, 2025 was $2.19 million, or - $0.30 basic and diluted loss per share compared to a net loss of $2.27 million, or - $0.37 basic and diluted loss per share, for the nine months ending September 30, 2024.
Total expenses for the three months ended September 30, 2025 increased to $815,000 from $498,000 for the quarter ended September 30, 2024.
Total expenses for the nine months ending September 30, 2025 increased to $4.99 million from $1.67 million for the nine months ending September 30, 2024.

As of September 30, 2025, restricted cash and cash equivalents increased by $1.28 million or 21.7%, to $7.18 million, from $5.9 million as of December 31, 2024.

The Balanced Yield Token (EtaCat Re) is tracking approximately 25% annual return, exceeding its 20% target, while the High Yield Token (ZetaCat Re) remains on track to meet its 42% target.

Oxbridge Re Holdings Limited is considering introducing regular dividend payouts on its security-backed CatRe tokens, moving away from a purely annual payout model.